Adult-Onset Hypogonadism
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
In August 2015, an expert colloquium commissioned by the Sexual Medicine Society of North America (SMSNA) convened in Washington, DC, to discuss the common clinical scenario of men who present with low testosterone (T) and associated signs and symptoms accompanied by low or normal gonadotropin levels. This syndrome is not classical primary (testicular failure) or secondary (pituitary or hypothalamic failure) hypogonadism because it may have elements of both presentations. The panel designated this syndrome adult-onset hypogonadism (AOH) because it occurs commonly in middle-age and older men. The SMSNA is a not-for-profit society established in 1994 to promote, encourage, and support the highest standards of practice, research, education, and ethics in the study of human sexual function and dysfunction. The panel consisted of 17 experts in men's health, sexual medicine, urology, endocrinology, and methodology. Participants declared potential conflicts of interest and were SMSNA members and nonmembers. The panel deliberated regarding a diagnostic process to document signs and symptoms of AOH, the rationale for T therapy, and a monitoring protocol for T-treated patients. The evaluation and management of hypogonadal syndromes have been addressed in recent publications (ie, the Endocrine Society, the American Urological Association, and the International Society for Sexual Medicine). The primary purpose of this document was to support health care professionals in the development of a deeper understanding of AOH, particularly in how it differs from classical primary and secondary hypogonadism, and to provide a conceptual framework to guide its diagnosis, treatment, and follow-up.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2354 · Cited by 1,954
Feldman, H. A., Longcope, C., Derby, C. A., Johannes, C. B., Araujo, A. B., Coviello, A. D., Bremner, W. J., & McKinlay, J. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8201 · Cited by 1,861
Identification of late-onset hypogonadism in middle-aged and elderly men
Wu, F. C. W., Tajar, A., Beynon, J. M., Pye, S. R., Silman, A. J., Finn, J. D., O'Neill, T. W., Bartfai, G., Casanueva, F. F., Forti, G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0911101 · Cited by 1,544 · cited 1×
“1% of men had symptomatic late-onset hypogonadism (LOH), defined as low total and free T levels with at least 3 sexual symptoms.(11)”
BackgroundDing, E. L., Song, Y., Malik, V. S., & Liu, S. (2006) · JAMA · doi:10.1001/jama.295.11.1288 · Cited by 1,354
Vigen, R. (2013) · JAMA · doi:10.1001/jama.2013.280386 · Cited by 1,003
Wu, F. C. W., Tajar, A., Pye, S. R., Silman, A. J., Finn, J. D., O'Neill, T. W., Bartfai, G., Casanueva, F., Forti, G., Giwercman, A., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1972 · Cited by 939
Laaksonen, D. E., Niskanen, L., Punnonen, K., Nyyssönen, K., Tuomainen, T.-P., Valkonen, V.-P., Salonen, R., & Salonen, J. T. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1036 · Cited by 920
Effects of Testosterone Treatment in Older Men
Snyder, P. J., Bhasin, S., Cunningham, G. R., Matsumoto, A. M., Stephens-Shields, A. J., Cauley, J. A., Gill, T. M., Barrett-Connor, E., Swerdloff, R. S., Wang, C., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1506119 · Cited by 890
Gonadal Steroids and Body Composition, Strength, and Sexual Function in Men
Finkelstein, J. S., Lee, H., Burnett-Bowie, S.-A. M., Pallais, J. C., Yu, E. W., Borges, L. F., Jones, B. F., Barry, C. V., Wulczyn, K. E., Thomas, B. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1206168 · Cited by 782
Research works printed but not linked: 88
- Dean, 2015, The International Society for Sexual Medicine's process of care for the assessment and management of testosterone deficiency in adult men, J Sex Med, 12, 1660
- Guay, 2010, Hypogonadism in men with erectile dysfunction may be related to a host of chronic illnesses, Int J Impot Res, 22, 9, 10.1038/ijir.2009.46 · DOI
- Maseroli, 2015, Prevalence of endocrine and metabolic disorders in subjects with erectile dysfunction: a comparative study, J Sex Med, 12, 956
- Corona, 2014, Characteristics of compensated hypogonadism in patients with sexual dysfunction, J Sex Med, 11, 1823
- Nieschlag, 1982, Reproductive functions in young fathers and grandfathers, J Clin Endocrinol Metab, 55, 676, 10.1210/jcem-55-4-676 · DOI · Paper page
- Yeap, 2009, Healthier lifestyle predicts higher circulating testosterone in older men: the Health In Men Study, Clin Endocrinol (Oxf), 70, 455, 10.1111/j.1365-2265.2008.03372.x · DOI · Paper page
- Rubens, 1974, Further studies on Leydig cell function in old age, J Clin Endocrinol Metab, 39, 40, 10.1210/jcem-39-1-40 · DOI · Paper page
- Araujo, 2011, Endocrinology of the aging male, Best Pract Res Clin Endocrinol Metab, 25, 303, 10.1016/j.beem.2010.11.004 · DOI · Paper page
- Takahashi, 2005, Graded inhibition of pulsatile luteinizing hormone secretion by a selective gonadotropin-releasing hormone (GnRH)-receptor antagonist in healthy men: evidence that age attenuates hypothalamic GnRH outflow, J Clin Endocrinol Metab, 90, 2768, 10.1210/jc.2004-2521 · DOI
- Winters, 1997, Serum LH concentrations in hypogonadal men during transdermal testosterone replacement through scrotal skin: further evidence that ageing enhances testosterone negative feedback. The Testoderm Study Group, Clin Endocrinol (Oxf), 47, 317, 10.1046/j.1365-2265.1997.2551065.x · DOI · Paper page
- Zumoff, 1982, Age variation of the 24 hour mean plasma concentration of androgens, estrogens, and gonadotropins in normal adult men, J Clin Endocrinol Metab, 54, 534, 10.1210/jcem-54-3-534 · DOI · Paper page
- MacDonald, 2010, The impact of body mass index on semen parameters and reproductive hormones in human males: a systematic review with meta-analysis, Hum Reprod Update, 16, 293, 10.1093/humupd/dmp047 · DOI · Paper page
- Faris, 2010, Metabolic sequelae associated with androgen deprivation therapy for prostate cancer, Curr Opin Endocrinol Diabetes Obes, 17, 240, 10.1097/MED.0b013e3283391fd1 · DOI · Paper page
- Shores, 2006, Low serum testosterone and mortality in male veterans, Arch Intern Med, 166, 1660, 10.1001/archinte.166.15.1660 · DOI · Paper page
- Corona, 2006, Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction, Eur Urol, 50, 595, 10.1016/j.eururo.2006.02.053 · DOI · Paper page
- Ashby, 2014, Hypogonadism in human immunodeficiency virus-positive men, Korean J Urol, 55, 9, 10.4111/kju.2014.55.1.9 · DOI
- Crum-Cianflone, 2007, Erectile dysfunction and hypogonadism among men with HIV, AIDS Patient Care STDS, 21, 9, 10.1089/apc.2006.0071 · DOI · Paper page
- De Ryck, 2013, Erectile dysfunction, testosterone deficiency, and risk of coronary heart disease in a cohort of men living with HIV in Belgium, J Sex Med, 10, 1816
- Moreno-Pérez, 2009, Hypogonadism, erectile dysfunction and endothelial dysfunction among HIV-infected men, Med Clin (Barc), 132, 311, 10.1016/j.medcli.2008.07.018 · DOI
- Richardson, 2007, Letrozole versus testosterone: a single-center pilot study of HIV-infected men who have sex with men on highly active anti-retroviral therapy (HAART) with hypoactive sexual desire disorder and raised estradiol levels, J Sex Med, 4, 502
- Rochira, 2011, Premature decline of serum total testosterone in HIV-infected men in the HAART-era, PLoS One, 6, e28512, 10.1371/journal.pone.0028512 · DOI · Paper page
- Sadeghi-Nejad, 2010, Sexually transmitted diseases and sexual function, J Sex Med, 7, 389
- Tripathy, 2015, Endocrine alterations in HIV-infected patients, Indian J Endocrinol Metab, 19, 143, 10.4103/2230-8210.146870 · DOI
- Zona, 2012, Erectile dysfunction is more common in young to middle-aged HIV-infected men than in HIV-uninfected men, J Sex Med, 9, 1923
- Thompson, 1994, Prevention of male infertility, Urol Clin North Am, 21, 365, 10.1016/S0094-0143(21)00613-3 · doi:10.1016/s0094-0143(21)00613-3
- Rahnema, 2014, Anabolic steroid-induced hypogonadism: diagnosis and treatment, Fertil Steril, 101, 1271, 10.1016/j.fertnstert.2014.02.002 · DOI · Paper page
- Birthi, 2015, Hypogonadism associated with long-term opioid therapy: a systematic review, J Opioid Manag, 11, 255, 10.5055/jom.2015.0274 · DOI
- Schooling, 2013, The effect of statins on testosterone in men and women, a systematic review and meta-analysis of randomized controlled trials, BMC Med, 11, 57, 10.1186/1741-7015-11-57 · DOI · Paper page
- Howell, 2005, Spermatogenesis after cancer treatment: damage and recovery, J Natl Cancer Inst Monogr, 34, 12, 10.1093/jncimonographs/lgi003 · DOI · Paper page
- Attal, 2010, Endocrine aspects of obstructive sleep apnea, J Clin Endocrinol Metab, 95, 483, 10.1210/jc.2009-1912 · DOI · Paper page
- Luboshitzky, 2002, Decreased pituitary-gonadal secretion in men with obstructive sleep apnea, J Clin Endocrinol Metab, 87, 3394, 10.1210/jcem.87.7.8663 · doi:10.1210/jcem.87.7.8663 · Paper page
- Baum, 1982, The use of psychological and neuroendocrinological measurements in the study of stress, Health Psychol, 1, 217, 10.1037/0278-6133.1.3.217 · DOI
- Nilsson, 1995, Adverse effects of psychosocial stress on gonadal function and insulin levels in middle-aged males, J Intern Med, 237, 479, 10.1111/j.1365-2796.1995.tb00873.x · DOI · Paper page
- Singer, 1992, Subnormal serum testosterone levels in male internal medicine residents, Steroids, 57, 86, 10.1016/0039-128X(92)90035-8 · DOI
- Kalinchenko, 2010, Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study, Clin Endocrinol (Oxf), 73, 602, 10.1111/j.1365-2265.2010.03845.x · DOI · Paper page
- Aversa, 2010, Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study, J Sex Med, 7, 3495
- Gianatti, 2014, Effect of testosterone treatment on glucose metabolism in men with type 2 diabetes: a randomized controlled trial, Diabetes Care, 37, 2098, 10.2337/dc13-2845 · DOI · Paper page
- Gopal, 2010, Treatment of hypogonadism with testosterone in patients with type 2 diabetes mellitus, Endocr Pract, 16, 570, 10.4158/EP09355.OR · DOI
- Hammoud, 2009, Effect of Roux-en-Y gastric bypass surgery on the sex steroids and quality of life in obese men, J Clin Endocrinol Metab, 94, 1329, 10.1210/jc.2008-1598 · DOI · Paper page
- Anderson, 1974, Sex-hormone-binding globulin, Clin Endocrinol (Oxf), 3, 69, 10.1111/j.1365-2265.1974.tb03298.x · DOI · Paper page
- Le M, Flores D, May D et al. Current practices of measuring and reference range reporting of free and total testosterone in the United States [published online ahead of print December 18, 2015]. J Urol. 2016;195:1556-1561. · DOI
- Shea, 2014, Free testosterone: clinical utility and important analytical aspects of measurement, Adv Clin Chem, 63, 59, 10.1016/B978-0-12-800094-6.00002-9 · DOI
- Dandona, 2010, A practical guide to male hypogonadism in the primary care setting, Int J Clin Pract, 64, 682, 10.1111/j.1742-1241.2010.02355.x · DOI · Paper page
- Buvat, 2013, Testosterone deficiency in men: systematic review and standard operating procedures for diagnosis and treatment, J Sex Med, 10, 245
- Rosen, 2011, The NERI Hypogonadism Screener: psychometric validation in male patients and controls, Clin Endocrinol (Oxf), 74, 248, 10.1111/j.1365-2265.2010.03925.x · DOI · Paper page
- Hak, 2002, Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study, J Clin Endocrinol Metab, 87, 3632, 10.1210/jcem.87.8.8762 · doi:10.1210/jcem.87.8.8762 · Paper page
- Haddad, 2007, Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials, Mayo Clin Proc, 82, 29, 10.1016/S0025-6196(11)60964-6 · DOI · Paper page
- Xu, 2013, Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials, BMC Med, 11, 108, 10.1186/1741-7015-11-108 · DOI · Paper page
- Layton, 2015, Comparative safety of testosterone dosage forms, JAMA Intern Med, 175, 1187, 10.1001/jamainternmed.2015.1573 · DOI · Paper page
- Isom-Batz, 2005, Testosterone as a predictor of pathological stage in clinically localized prostate cancer, J Urol, 173, 1935
- Schatzl, 2003, Associations of serum testosterone with microvessel density, androgen receptor density and androgen receptor gene polymorphism in prostate cancer, J Urol, 169, 1312
- Hsing, 2001, Hormones and prostate cancer: what's next?, Epidemiol Rev, 23, 42, 10.1093/oxfordjournals.epirev.a000795 · DOI · Paper page
- Roddam, 2008, Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies, J Natl Cancer Inst, 100, 170, 10.1093/jnci/djm323 · DOI · Paper page
- Yamamoto, 2007, Preoperative serum testosterone level as an independent predictor of treatment failure following radical prostatectomy, Eur Urol, 52, 696, 10.1016/j.eururo.2007.03.052 · DOI
- Khera, 2014, A new era of testosterone and prostate cancer: from physiology to clinical implications, Eur Urol, 65, 115, 10.1016/j.eururo.2013.08.015 · DOI · Paper page
- Morgentaler, 2011, Testosterone therapy in men with untreated prostate cancer, J Urol, 185, 1256
- Song, 2014, Physiological normal levels of androgen inhibit proliferation of prostate cancer cells in vitro, Asian J Androl, 16, 864, 10.4103/1008-682X.129132 · doi:10.4103/1008-682x.129132
- Sonnenschein, 1989, Negative controls of cell proliferation: human prostate cancer cells and androgens, Cancer Res, 49, 3474
- Chuu, 2005, Androgen causes growth suppression and reversion of androgen-independent prostate cancer xenografts to an androgen-stimulated phenotype in athymic mice, Cancer Res, 65, 2082, 10.1158/0008-5472.CAN-04-3992 · DOI
- Schweizer, 2015, Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: results from a pilot clinical study, Sci Transl Med, 7, 269ra2, 10.1126/scitranslmed.3010563 · DOI · Paper page
- Gooren, 2007, Diagnosing and treating testosterone deficiency in different parts of the world: results from global market research, Aging Male, 10, 173, 10.1080/13685530701600885 · DOI
- Moore, 2015, Testosterone replacement therapy on the natural history of prostate disease, Curr Urol Rep, 16, 51, 10.1007/s11934-015-0526-6 · DOI
- van der Sluis, 2012, Intraprostatic testosterone and dihydrotestosterone, part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer, BJU Int, 109, 176, 10.1111/j.1464-410X.2011.10651.x · DOI
- Page, 2011, Dihydrotestosterone administration does not increase intraprostatic androgen concentrations or alter prostate androgen action in healthy men: a randomized-controlled trial, J Clin Endocrinol Metab, 96, 430, 10.1210/jc.2010-1865 · DOI · Paper page
- Pechersky, 2002, Androgen administration in middle-aged and ageing men: effects of oral testosterone undecanoate on dihydrotestosterone, oestradiol and prostate volume, Int J Androl, 25, 119, 10.1046/j.1365-2605.2002.00335.x · DOI · Paper page
- Vignozzi, 2012, Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells, J Endocrinol, 214, 31, 10.1530/JOE-12-0142 · DOI · Paper page
- Amano, 2010, Testosterone replacement therapy by testosterone ointment relieves lower urinary tract symptoms in late onset hypogonadism patients, Aging Male, 13, 242, 10.3109/13685538.2010.487552 · DOI
- Francomano, 2014, Effects of 5-year treatment with testosterone undecanoate on lower urinary tract symptoms in obese men with hypogonadism and metabolic syndrome, Urology, 83, 167, 10.1016/j.urology.2013.08.019 · DOI
- Haider, 2009, Concurrent improvement of the metabolic syndrome and lower urinary tract symptoms upon normalisation of plasma testosterone levels in hypogonadal elderly men, Andrologia, 41, 7, 10.1111/j.1439-0272.2008.00880.x · DOI
- Kalinchenko, 2008, Beneficial effects of testosterone administration on symptoms of the lower urinary tract in men with late-onset hypogonadism: a pilot study, Aging Male, 11, 57, 10.1080/13685530801953994 · DOI
- Karazindiyanoğlu, 2008, The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadism, Aging Male, 11, 146, 10.1080/13685530802290438 · DOI
- Pearl, 2013, Testosterone supplementation does not worsen lower urinary tract symptoms, J Urol, 190, 1828
- Shigehara, 2011, Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: a randomised controlled study, Aging Male, 14, 53, 10.3109/13685538.2010.518178 · DOI · Paper page
- 1990, Contraceptive efficacy of testosterone-induced azoospermia in normal men. World Health Organization Task Force on methods for the regulation of male fertility, Lancet, 336, 955, 10.1016/0140-6736(90)92416-F · DOI · Paper page
- Page, 2006, Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist, J Clin Endocrinol Metab, 91, 4374, 10.1210/jc.2006-1411 · DOI · Paper page
- Gu, 2009, Multicenter contraceptive efficacy trial of injectable testosterone undecanoate in Chinese men, J Clin Endocrinol Metab, 94, 1910, 10.1210/jc.2008-1846 · DOI · Paper page
- Ko, 2012, Empirical medical therapy for idiopathic male infertility: a survey of the American Urological Association, J Urol, 187, 973
- Kennedy, 1962, Stimulation of erythropoiesis by androgenic hormones, Ann Intern Med, 57, 917, 10.7326/0003-4819-57-6-917 · DOI
- Delev, 2013, Effect of testosterone propionate on erythropoiesis after experimental orchiectomy, Folia Med (Plovdiv), 55, 51, 10.2478/folmed-2013-0017 · DOI
- Swerdloff, 2003, Three-year follow-up of androgen treatment in hypogonadal men: preliminary report with testosterone gel, Aging Male, 6, 207, 10.1080/tam.6.3.207.211 · doi:10.1080/tam.6.3.207.211 · Paper page
- Bachman, 2014, Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point, J Gerontol A Biol Sci Med Sci, 69, 725, 10.1093/gerona/glt154 · DOI · Paper page
- Siddique, 2004, Reversal of polycythaemia induced by intramuscular androgen replacement using transdermal testosterone therapy, Clin Endocrinol (Oxf), 60, 143, 10.1111/j.1365-2265.2004.01933.x · DOI
- Jick, 2013, The risk of adverse outcomes in association with use of testosterone products: a cohort study using the UK-based general practice research database, Br J Clin Pharmacol, 75, 260, 10.1111/j.1365-2125.2012.04326.x · DOI
- Schreijer, 2010, High hematocrit as a risk factor for venous thrombosis. Cause or innocent bystander?, Haematologica, 95, 182, 10.3324/haematol.2009.017285 · DOI
- Braekkan, 2010, Hematocrit and risk of venous thromboembolism in a general population. The Tromso study, Haematologica, 95, 270, 10.3324/haematol.2009.008417 · DOI · Paper page
- Vayá, 2013, Hemorheological parameters as independent predictors of venous thromboembolism, Clin Hemorheol Microcirc, 53, 131, 10.3233/CH-2012-1581 · DOI
- De Stefano, 2008, Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments, Haematologica, 93, 372, 10.3324/haematol.12053 · DOI · Paper page
- Glueck, 2014, Testosterone, thrombophilia, thrombosis, Blood Coagul Fibrinolysis, 25, 683, 10.1097/MBC.0000000000000126 · DOI
Cited by
Evaluation and Management of Testosterone Deficiency: AUA Guideline
Mulhall, J. P., Trost, L. W., Brannigan, R. E., Kurtz, E. G., Redmon, J. B., Chiles, K. A., Lightner, D. J., Miner, M. M., Murad, M. H., Nelson, C. J., et al. (2018) · Journal of Urology · doi:10.1016/j.juro.2018.03.115 · Cited by 766
Self-citationLifestyle and fertility: the influence of stress and quality of life on male fertility
Ilacqua, A., Izzo, G., Emerenziani, G. P., Baldari, C., & Aversa, A. (2018) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-018-0436-9 · Cited by 313
Khera, M., Adaikan, G., Buvat, J., Carrier, S., El-Meliegy, A., Hatzimouratidis, K., McCullough, A., Morgentaler, A., Torres, L. O., & Salonia, A. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2016.10.009 · Cited by 177
Self-citationSociety for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism
Jayasena, C. N., Anderson, R. A., Llahana, S., Barth, J. H., MacKenzie, F., Wilkes, S., Smith, N., Sooriakumaran, P., Minhas, S., Wu, F. C. W., et al. (2022) · Clinical Endocrinology · doi:10.1111/cen.14633 · Cited by 147
“Cross‐sectional and longitudinal epidemiologic data have identified an age‐related decline in serum testosterone, particularly the circulating free fraction, and yet much of this results from accumulating co‐morbidities, such as obesity, chronic disease, medications and frailty, rather than from primary disorders of t…”
BackgroundSowithayasakul, P., Buschmann, L. K., Boekhoff, S., & Müller, H. L. (2021) · European Journal of Pediatrics · doi:10.1007/s00431-020-03915-x · Cited by 20
Metadata
- Authors
- Khera, M., Broderick, G. A., Carson, C. C., Dobs, A. S., Faraday, M. M., Goldstein, I., Hakim, L. S., Hellstrom, W. J. G., Kacker, R., Köhler, T. S., Mills, J. N., Miner, M., Sadeghi-Nejad, H., Seftel, A. D., Sharlip, I. D., Winters, S. J., & Burnett, A. L.
- Venue
- Mayo Clinic Proceedings
- Publisher
- Elsevier BV
- Published
- 2016-07
- Volume
- 91
- Issue
- 7
- Pages
- 908-926
- ISSN
- 0025-6196 (ISSN-L)
- OpenAlex
- W2468038015
- Cited by
- 96
- References
- 57
- FWCI
- 9.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adult-Onset Hypogonadism. https://app.cochat.ai/papers/10.1016/j.mayocp.2016.04.022
- The paper
- Khera, M., Broderick, G. A., Carson, C. C., Dobs, A. S., Faraday, M. M., Goldstein, I., Hakim, L. S., Hellstrom, W. J. G., Kacker, R., Köhler, T. S., Mills, J. N., Miner, M., Sadeghi-Nejad, H., Seftel, A. D., Sharlip, I. D., Winters, S. J., & Burnett, A. L. (2016). Adult-Onset Hypogonadism. Mayo Clinic Proceedings. https://doi.org/10.1016/j.mayocp.2016.04.022
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.